DaVita HealthCare Partners Inc (DVA)vsEnhabit Inc. (EHAB)
DVA
DaVita HealthCare Partners Inc
$178.47
+2.18%
HEALTHCARE · Cap: $11.73B
EHAB
Enhabit Inc.
$13.80
+0.07%
HEALTHCARE · Cap: $706.91M
Smart Verdict
WallStSmart Research — data-driven comparison
DaVita HealthCare Partners Inc generates 1216% more annual revenue ($14.01B vs $1.06B). DVA leads profitability with a 6.0% profit margin vs -0.3%. DVA earns a higher WallStSmart Score of 70/100 (B).
DVA
Strong Buy70
out of 100
Grade: B
EHAB
Hold39
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-12.9%
Fair Value
$127.80
Current Price
$178.47
$50.67 premium
Intrinsic value data unavailable for EHAB.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Growing faster than its price suggests
Every $100 of equity generates 81 in profit
Earnings expanding 55.8% YoY
Conservative balance sheet, low leverage
Attractively priced relative to earnings
Reasonable price relative to book value
Areas to Watch
6.0% margin — thin
Weak financial health signals
Distress zone — elevated risk
1.9% revenue growth
2.9% earnings growth
Distress zone — elevated risk
Smaller company, higher risk/reward
Comparative Analysis Report
WallStSmart ResearchBull Case : DVA
The strongest argument for DVA centers on PEG Ratio, Return on Equity, EPS Growth. PEG of 0.45 suggests the stock is reasonably priced for its growth.
Bull Case : EHAB
The strongest argument for EHAB centers on Price/Book.
Bear Case : DVA
The primary concerns for DVA are Profit Margin, Piotroski F-Score, Altman Z-Score.
Bear Case : EHAB
The primary concerns for EHAB are Revenue Growth, EPS Growth, Altman Z-Score.
Key Dynamics to Monitor
DVA profiles as a value stock while EHAB is a turnaround play — different risk/reward profiles.
EHAB carries more volatility with a beta of 0.96 — expect wider price swings.
DVA is growing revenue faster at 5.2% — sustainability is the question.
DVA generates stronger free cash flow (320M), providing more financial flexibility.
Bottom Line
DVA scores higher overall (70/100 vs 39/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
DaVita HealthCare Partners Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.
Enhabit Inc.
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Enhabit, Inc. provides home health and hospice services in the United States.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?